Novartis Makes Mayzent Case With More MS Data

 
• By Kevin Grogan
  
Wheelchair
Mayzent can help patients keep their mobility for over four years longer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category